CRO concept sector active, Kelun Pharma hits the daily limit

MaticHoleFiller · 2026-04-07T19:57:12+00:00

As of March 31st, 14:35, the CRO concept sector was active, with Kelaiying hitting the daily limit. Chengda Pharmaceutical, Nostege, Zhaoyan New Drug, and other stocks saw significant gains. Investment should be cautious; information is for reference only.

MaticHoleFiller

2026-04-07 19:57:12

Abstract generation in progress

March 31 news: As of 14:35, the CRO concept sector is active. Keliian Biotech reached the daily limit, and stocks including Chengda Pharmaceuticals, Nocsage, and Zhaoyan New Medicine are among the top gainers.

Statement: The market involves risks; investment is with caution. This article is automatically published based on a third-party database and does not represent the views of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there are discrepancies, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

A wealth of information and precise analysis—exclusively on the Sina Finance app

Editor: Xiaolang Quick News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes